Buy this Article for $7.95

Have a coupon or promotional code? Enter it here:

When you buy this you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.

Authors

  1. Aschenbrenner, Diane S. MS, APRN-BC

Abstract

* A new atypical antipsychotic drug, lurasidone (Latuda) has been approved to treat schizophrenia in adults.

 

* As with other drugs in this class, lurasidone isn't approved for older adults with dementia-related psychosis.

 

* Lurasidone has the same adverse effects profile as other atypical antipsychotics, including an increased risk of death, particularly from cerebrovascular causes.